Clinical Trials Logo

Advanced Gastric Cancer clinical trials

View clinical trials related to Advanced Gastric Cancer.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03255811 Enrolling by invitation - Clinical trials for Advanced Gastric Cancer

Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer

Start date: March 25, 2017
Phase: N/A
Study type: Interventional

At present, apatinib was approved for the treatment of advanced gastric cancer after second-line or gastroesophageal junction adenocarcinoma, is in the second one, experience of medication, clinical data, no chemotherapy so now intends to carry out 40 cases of small sample exploratory research, in the conventional chemotherapy after the onset, with APA for Nigeria maintenance treatment, with a preliminary understanding of apatinib in first-line advanced gastric cancer to maintain the efficacy and safety of the treatment, and explore the feasibility of anti generate small molecule targeted therapy in advanced gastric cancer vascular pattern.

NCT ID: NCT00854854 Enrolling by invitation - Clinical trials for Advanced Gastric Cancer

Efficacy Study of TKcell in Advanced Gastric Cancer

Start date: January 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine efficacy of NKCell combined FOLFOX-4 chemotherapy in gastric cancer